Mutations in NONO lead to syndromic intellectual disability and inhibitory synaptic defects.
Dennis MircsofMaéva LangouëtMarlène RioSebastien MouttonKarine Siquier-PernetChristine Bole-FeysotNicolas CagnardPatrick NitschkeLudmila GasparMatej ŽnidaričOlivier AlibeuAnn-Kristina FritzDavid P WolferAileen SchröterGiovanna BosshardMarkus RudinChristina KoesterFlorence CrestaniPetra SeebeckNathalie BoddaertKatrina Prescottnull nullRochelle HinesSteven J MossJean-Marc FritschyArnold MunnichJeanne AmielSteven A BrownShiva K TyagarajanLaurence ColleauxPublished in: Nature neuroscience (2015)
The NONO protein has been characterized as an important transcriptional regulator in diverse cellular contexts. Here we show that loss of NONO function is a likely cause of human intellectual disability and that NONO-deficient mice have cognitive and affective deficits. Correspondingly, we find specific defects at inhibitory synapses, where NONO regulates synaptic transcription and gephyrin scaffold structure. Our data identify NONO as a possible neurodevelopmental disease gene and highlight the key role of the DBHS protein family in functional organization of GABAergic synapses.